🟥HCLTech revises margin and constant currency revenue growth guidance for FY26
Margin guidance lowered to 17.0% to 18.0% from 18% to19%.Constant currency revenue guidance for FY26 seen at 3% to 5%.Raises lower end of revenue guidance from 2% to 3% #StockToWatch#stocks#Nifty
🟩#Glenmark Subsidiary IGI & AbbVie Strike $700 Mn Global Licensing Deal For ISB 2001, a next-gen cancer drug
IGI will receive an upfront payment of $700 million and is eligible to receive up to $1.225 billion in development, regulatory, and commercial milestone payments.#stocks
Loan accounts of Gensol Engineering and Gensol EV Lease Pvt Ltd have been downgraded to NPA status and appropriate ECL provisions have been made. IREDA highlighted that the loans are secured by hypothecation of project assets, extended charge of movable and immovable project .
🟥#IREDA
Net Profit Down 35.7% at ₹247 Cr Vs ₹384 Cr (YoY)
Revenue Up 28.9% at ₹1,947 Cr Vs ₹1,510 Cr (YoY)
Gross NPA at 4.13% Vs 2.45% (QoQ)
Net NPA at 2.06% Vs 1.35% (QoQ)
IREDA Q1 asset quality hit after it classifies various exposures worth over ₹1,500 crore as NPA.
🟥#TataElxsi has reported a muted Q1 FY26 performance, with net profit dropping 21% QoQ to ₹144.36 crore, below the expected ₹163 crore. Revenue declined 1.8% sequentially to ₹892 crore, missing Street estimates of ₹908 crore.StockToWatch #StockMarketindia#stocks#Nifty#BSE
#TCS reports a 4% rise in net profit for Q1FY26, in line with estimates, while revenue declined sequentially.Revenue at ₹63,437 crore; Decline of 3.1% YoY, Net Profits at 12760 crore.
#Infosys & #Wipro ADR down more than 4%
TCS report decrease in their biggest clients.
#Results